- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: Muscimol
01.1: 8 residues within 4Å:- Chain A: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain B: R.125
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:Y.262
- Hydrogen bonds: A:E.217, A:Y.219, A:T.265, A:Y.268, B:R.125
- pi-Stacking: A:Y.219
01.11: 8 residues within 4Å:- Chain B: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain C: R.125
7 PLIP interactions:6 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:Y.262
- Hydrogen bonds: B:E.217, B:Y.219, B:T.265, B:Y.268, C:R.125
- pi-Stacking: B:Y.219
01.21: 8 residues within 4Å:- Chain C: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain D: R.125
7 PLIP interactions:6 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:Y.262
- Hydrogen bonds: C:E.217, C:Y.219, C:T.265, C:Y.268, D:R.125
- pi-Stacking: C:Y.219
01.31: 9 residues within 4Å:- Chain D: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
- Chain E: R.125, M.177
7 PLIP interactions:1 interactions with chain E, 6 interactions with chain D- Hydrogen bonds: E:R.125, D:E.217, D:Y.219, D:T.265, D:Y.268
- Hydrophobic interactions: D:Y.262
- pi-Stacking: D:Y.219
01.42: 9 residues within 4Å:- Chain A: Y.123, R.125
- Chain E: F.159, E.217, S.218, Y.219, Y.262, T.265, Y.268
8 PLIP interactions:6 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:Y.262, A:Y.123
- Hydrogen bonds: E:E.217, E:Y.219, E:T.265, E:Y.268, A:R.125
- pi-Stacking: E:Y.219
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x A8Z: Tetrahydrodeoxycorticosterone(Non-covalent)
A8Z.4: 6 residues within 4Å:- Chain A: L.285, T.293, Y.347, N.471, W.475
- Ligands: D12.5
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.285, A:L.285, A:W.475, A:W.475, A:W.475
- Hydrogen bonds: A:T.293, A:T.293, A:N.471
A8Z.14: 6 residues within 4Å:- Chain B: L.285, T.293, Y.347, N.471, W.475
- Ligands: D12.15
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:L.285, B:L.285, B:W.475, B:W.475, B:W.475
- Hydrogen bonds: B:T.293, B:T.293, B:N.471
A8Z.24: 6 residues within 4Å:- Chain C: L.285, T.293, Y.347, N.471, W.475
- Ligands: D12.25
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:L.285, C:L.285, C:W.475, C:W.475, C:W.475
- Hydrogen bonds: C:T.293, C:T.293, C:N.471
A8Z.34: 6 residues within 4Å:- Chain D: L.285, T.293, Y.347, N.471, W.475
- Ligands: D12.35
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:L.285, D:L.285, D:W.475, D:W.475, D:W.475
- Hydrogen bonds: D:T.293, D:T.293, D:N.471
A8Z.45: 6 residues within 4Å:- Chain E: L.285, T.293, Y.347, N.471, W.475
- Ligands: D12.46
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:L.285, E:L.285, E:W.475, E:W.475, E:W.475
- Hydrogen bonds: E:T.293, E:T.293, E:N.471
- 5 x D12: DODECANE(Non-covalent)
D12.5: 4 residues within 4Å:- Chain A: T.293, Y.467, L.472
- Ligands: A8Z.4
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.293, A:Y.467
D12.15: 4 residues within 4Å:- Chain B: T.293, Y.467, L.472
- Ligands: A8Z.14
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.293, B:Y.467
D12.25: 4 residues within 4Å:- Chain C: T.293, Y.467, L.472
- Ligands: A8Z.24
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:T.293, C:Y.467
D12.35: 4 residues within 4Å:- Chain D: T.293, Y.467, L.472
- Ligands: A8Z.34
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:T.293, D:Y.467
D12.46: 4 residues within 4Å:- Chain E: T.293, Y.467, L.472
- Ligands: A8Z.45
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:T.293, E:Y.467
- 5 x OCT: N-OCTANE(Non-covalent)
OCT.6: 3 residues within 4Å:- Chain A: V.301, W.304
- Chain E: A.364
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:A.364, A:V.301, A:W.304
OCT.16: 3 residues within 4Å:- Chain A: A.364
- Chain B: V.301, W.304
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:V.301, B:W.304, A:A.364
OCT.26: 3 residues within 4Å:- Chain B: A.364
- Chain C: V.301, W.304
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:V.301, C:W.304, B:A.364
OCT.36: 3 residues within 4Å:- Chain C: A.364
- Chain D: V.301, W.304
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:A.364, D:V.301, D:W.304
OCT.41: 3 residues within 4Å:- Chain D: Y.367
- Chain E: V.301, W.304
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain E- Hydrophobic interactions: D:Y.367, E:V.301, E:W.304
- 20 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
HEX.7: 2 residues within 4Å:- Chain A: Y.458, S.459
Ligand excluded by PLIPHEX.8: 1 residues within 4Å:- Chain A: I.477
Ligand excluded by PLIPHEX.9: 2 residues within 4Å:- Chain A: W.304, I.461
Ligand excluded by PLIPHEX.10: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPHEX.17: 2 residues within 4Å:- Chain B: Y.458, S.459
Ligand excluded by PLIPHEX.18: 1 residues within 4Å:- Chain B: I.477
Ligand excluded by PLIPHEX.19: 2 residues within 4Å:- Chain B: W.304, I.461
Ligand excluded by PLIPHEX.20: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPHEX.27: 2 residues within 4Å:- Chain C: Y.458, S.459
Ligand excluded by PLIPHEX.28: 1 residues within 4Å:- Chain C: I.477
Ligand excluded by PLIPHEX.29: 2 residues within 4Å:- Chain C: W.304, I.461
Ligand excluded by PLIPHEX.30: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPHEX.37: 2 residues within 4Å:- Chain D: Y.458, S.459
Ligand excluded by PLIPHEX.38: 1 residues within 4Å:- Chain D: I.477
Ligand excluded by PLIPHEX.39: 2 residues within 4Å:- Chain D: W.304, I.461
Ligand excluded by PLIPHEX.40: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPHEX.47: 2 residues within 4Å:- Chain E: Y.458, S.459
Ligand excluded by PLIPHEX.48: 1 residues within 4Å:- Chain E: I.477
Ligand excluded by PLIPHEX.49: 2 residues within 4Å:- Chain E: W.304, I.461
Ligand excluded by PLIPHEX.50: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., CryoEM structure of human rho1 GABAA receptor in complex with neurosteroid. To be published
- Release Date
- 2025-07-30
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x 01: Muscimol
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x A8Z: Tetrahydrodeoxycorticosterone(Non-covalent)
- 5 x D12: DODECANE(Non-covalent)
- 5 x OCT: N-OCTANE(Non-covalent)
- 20 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., CryoEM structure of human rho1 GABAA receptor in complex with neurosteroid. To be published
- Release Date
- 2025-07-30
- Peptides
- Gamma-aminobutyric acid receptor subunit rho-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.